Novotech

As we step into 2025, we’re excited to continue partnering with our clients, partners, and team members worldwide. Here’s to a year of new opportunities, progress, and success together. Wishing you a prosperous New Year! #HappyNewYear #2024 #Novotech #ClinicalResearch #GlobalHealth #HappyNewYear

As 2024 draws to a close, we extend our heartfelt thanks to our clients, partners, and team members around the globe. Your trust, collaboration, and dedication have been instrumental in driving our mission is to enhance patient outcomes by accelerating the development of new treatments and therapies. This holiday season, we celebrate the progress we've made together and look forward to an exciting year ahead, filled with new opportunities to make a tangible difference in patients’ lives. From all of us at Novotech, we wish you and your loved ones a joyful holiday season! #SeasonsGreetings #HappyHolidays #Novotech”

Novotech’s Chris Chong, Senior Director - Clinical Services, and Wen Fen C., Senior Director - Project Management Asia, participates in the ESMO Asia 2024 Congress to connect with oncology experts and showcase how Novotech supports clinical trials across the Asia-Pacific region and globally. Novotech is committed to advancing oncology clinical trial across the Asia-Pacific region and globally. Connect with our team to explore how we can support your oncology trials. #ESMOAsia2024 #Oncology #Novotech

Novotech was proud to sponsor the 2024 Fierce 50 Gala, recognizing 50 brilliant visionaries driving transformation across life science and healthcare. Our representatives, Jamila Taylor, Head of Project Management US, and Taylor Graves, Manager Human Resources, joined this inspiring celebration. Key highlights included: 🔹Peter Lee (Microsoft) on AI’s role in improving clinical workflows and patient outcomes. 🔹Dr. Kevin Bennett on advancing health equity in rural areas. 🔹Kimberly Sears (Irth App) empowering Black women to combat healthcare disparities. 🔹Dr. Manica Balasegaram announcing Phase 3 results for a new antibiotic targeting resistant gonorrhea. 🔹Dr. Timothy Yu sharing progress in personalized medicine for rare genetic disorders. Congratulations to the Fierce 50 honorees for pushing boundaries, driving change, and redefining possibilities in healthcare and beyond. #Fierce50 #HealthcareInnovation #Novotech

The ASH Annual Meeting, held December 7–10 in San Diego, brought together global experts focused on advancing treatments for classical and malignant hematology. It was a great opportunity to discuss how Novotech’s extensive experience with 80 hematology studies can support your clinical development. If we missed the chance to connect during the event, we welcome the opportunity to discuss how Novotech can support your hematology trials. https://ow.ly/MbfO50Ut60k Craig Leach, Sarah Rose Anderson #Hematology #Novotech #ASH2024

Unlock insights into the future of precision medicine with Novotech’s webinar, "Precision Oncology and the Global Standard of Care", now available on-demand. Discover key global challenges and innovative solutions in precision oncology. Key topics: 🔹Standardizing precision oncology care worldwide. 🔹The role of clinical trials in increasing access to Next Generation Sequencing (NGS). 🔹Strategies to overcome operational and technical challenges. Gain insights from leading experts Dr. David Thomas, Dr. Chia-Chi (Josh) Lin, Dr. Chun-Hui Lee, Dr. Steve Yip, Vishal Doshi, Courtney Thornely and Nelson Lin. Access here: https://ow.ly/lkFC50Uskjh #ClinicalTrials #PrecisionOncology #Novotech

Novotech will once again participate in JPM Week in San Francisco, January 13-15, 2025, to engage with biotech leaders on advancing clinical development strategies. Our leadership team, Barry Murphy, Dr. Judith Ng-Cashin, M.D., Rick Farris, Dr. Yooni Kim, Dr. Ian Braithwaite and Dr. David Ng will be available at the following partnering events: 🔹Biotech Showcase (Gold Sponsor): Jan. 13–15, San Francisco Hilton. Meet with us: https://ow.ly/SPvP50UrGll 🔹Bio Partnering: Jan. 13–16, San Francisco Marriott Marquis. Meet with us: https://ow.ly/4OwE50UrGjP 🔹RESI: Jan. 14, San Francisco Marriott Marquis. Meet with us: https://ow.ly/4hUh50UrGq5 In addition, join Dr. Judith Ng-Cashin, Novotech’s Chief Medical Officer, at the Fierce JPM Week event at the Hyatt Embarcadero for her panel discussion “Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape” January 14, 11:10 am – 12 pm. https://ow.ly/NJat50UrGjQ #JPM2025 #ClinicalTrials #Novotech

Join us on December 17, 12:55–1:40 PM ET for a Novotech-sponsored panel discussion, "Partnering with Patients on Clinical Trials" as part of Endpoints Clinical Trials Day. This session will explore best practices for incorporating patient feedback into clinical trial design, accelerating recruitment, and fostering collaboration to improve trial outcomes. Speakers: 🔹Scott Schliebner, VP, Drug Development Consulting, Novotech. 🔹Melody Burchett, President, A Cure In Sight™. 🔹Dr. Layla Hosseini-Gerami, Chief Data Science Officer, Ignota Labs. 🔹Ken Getz, Executive Director, Research Professor (PHCM), Tufts Center for the Study of Drug Development. 🔹John Carroll, Founder & Editor, Endpoints News (Moderator). Learn how to design trials with a patient-centered approach. Register here: https://ow.ly/J4Oq50UrvU4 #ClinicalTrials #PatientEngagement #Novotech

Thank you to everyone who visited Novotech at the American Epilepsy Society (AES) 2024 Annual Meeting in Los Angeles. It was a great opportunity to discuss how Novotech’s extensive experience of almost 250 completed nervous system studies can support clinical development in epilepsy and related neurological conditions. If you didn’t have the chance to connect with Matt Nicola, Senior Director of Business Development, or Terra Johnston, Director of Regulatory Operations, feel free to reach out to learn how Novotech can help optimize your clinical trials. https://ow.ly/G1Wt50Uqs95 #AES2024 #EpilepsyResearch #Novotech

Thank you to those who connected with Novotech at the ASCEPT, APFP & APSA Joint Congress in Melbourne. Key sessions included: 🔹Dr. Karen Scalzo-Inguanti PhD and Dr. Melisa Rike Anggraeni presented on strategies to advance a potential therapeutic from candidate to clinic in a workshop moderated by Dr. Felicity Grzemski. 🔹Dr. Sharleen Menezes’ poster presentation highlighted nonclinical and manufacturing considerations for cell and gene therapies under the Innovation and Industry theme. For more information about Novotech’s Drug Development Consulting services, please reach out to us. https://ow.ly/OFXQ50UpGcI #ASCEPT2024 #DrugDevelopment #Novotech